Biomark Diagnostics Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 26, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	54	22	25	15	16	31
Market Cap Growth	222.12%	-9.92%	60.95%	-1.62%	-48.77%	128.35%
Enterprise Value	53	24	26	17	17	31
Last Close Price	0.58	0.27	0.30	0.21	0.23	0.42
PS Ratio	433.57	145.04	152.12	100.50	356.91	-
PB Ratio	61.97	12.85	-40.73	-13.42	-24.67	-386.98
P/TBV Ratio	61.97	12.85	-	-	-	-
EV/Sales Ratio	-	154.52	161.35	110.73	393.16	-
Debt / Equity Ratio	0.93	0.64	-2.54	-1.44	-3.09	-12.70
Net Debt / Equity Ratio	-0.86	-0.78	-2.28	-1.37	-2.49	-1.61
Net Debt / EBITDA Ratio	0.43	0.67	-0.82	-0.86	-1.24	-0.12
Net Debt / FCF Ratio	0.53	1.24	-1.41	-1.72	-1.25	-0.16
Asset Turnover	0.09	0.07	0.18	0.14	0.04	-
Quick Ratio	1.73	2.14	0.16	0.06	0.31	0.98
Current Ratio	1.73	2.14	0.16	0.08	0.33	1.00
Return on Equity (ROE)	-	-340.70%	-	-	-	-
Return on Assets (ROA)	-79.14%	-60.59%	-117.29%	-104.38%	-66.20%	-80.77%
Return on Capital Employed (ROCE)	-197.50%	-107.60%	1099.30%	197.40%	4328.70%	-3366.60%
Earnings Yield	-3.09%	-8.62%	-5.75%	-11.94%	-9.27%	-3.57%
FCF Yield	-2.66%	-4.90%	-3.98%	-5.96%	-8.06%	-2.64%
Buyback Yield / Dilution	-10.10%	-6.67%	-2.97%	-6.22%	-6.31%	-2.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.